Detalles de la búsqueda
1.
Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study.
J Clin Psychopharmacol
; 31(1): 108-14, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21192153
2.
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis.
Patient Prefer Adherence
; 15: 2239-2248, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34629867
3.
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
J Clin Psychopharmacol
; 29(3): 239-47, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19440077
4.
Development and preliminary validation of an integrated efficacy-tolerability composite measure for the evaluation of analgesics.
Pain
; 156(7): 1357-1365, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25867124
5.
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study.
Mayo Clin Proc
; 83(9): 1002-10, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18775200
Resultados
1 -
5
de 5
1
Próxima >
>>